Dutron Polymers (517437)
CyclicalScore breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹170 |
| Market Cap | ₹104.52 Cr |
| P/E Ratio | 24.84 |
| ROCE | 12.26% |
| ROE | 9.07% |
| Dividend Yield | 1.41% |
| Profit Growth | 88.68% |
| Debt/Equity | — |
| Sales Growth | -16.94% |
| 52-Week Range | ₹94.6 — ₹170 |
| Sector | Industrial Products |
| Book Value | ₹45.08 |
Strengths
- Profit growth of 88.68% and Piotroski F-Score of 6/9 indicate improving operational momentum.
- ROCE of 12.26% exceeds ROE of 9.07%, suggesting reasonable operating capital efficiency.
- Latest quarter net margin is about 4.3% (₹1 Cr profit on ₹23 Cr sales), showing some pricing or cost discipline.
- Dividend yield of 1.41% offers a modest income cushion while trading near its 52-week high reflects market confidence.
Concerns
- Sales declined 16.94%; top-line weakness makes the profit jump look fragile and potentially low-base driven.
- Valuation is stretched: P/E of 24.84 and P/B of 3.77 are high relative to ROE of 9.07%, leaving little margin of safety.
- Debt/Equity and promoter holding data are unavailable, making balance-sheet and governance assessment difficult.
- Absolute earnings are tiny—latest quarter net profit of ₹1 Cr—so any operational hiccup can sharply hit profits.
AI Analysis
I have to judge this business the way I judge any: would I be happy owning it for ten years? Dutron Polymers is a small ₹105 crore market cap player in industrial plastic products. At ₹170, the market is paying 24.84 times earnings and 3.77 times book value for a business that earned just 9.07% on equity last year. That is no Graham bargain. Book value is ₹45.08, so I am paying ₹170 for assets that generate modest returns. The top line fell 16.94%; that is a serious red flag in a competitive, likely commodity-like industry. A profit rise of 88.68% sounds attractive, but I am suspicious when profit jumps while sales shrink. It could be cost-cutting, a low base, or a cyclical upswing. The latest quarter's net profit is only ₹1 crore on ₹23 crore of sales—roughly 4.3% net margin—so absolute earning power is thin. The Piotroski score of 6 out of 9 shows some financial strength, and ROCE of 12.26% is better than ROE, but I do not know the debt picture because D/E is not available, and promoter holding is also undisclosed. Without those, I cannot fully trust the balance sheet. Dividend yield of 1.41% is modest. The stock sits near its 52-week high of ₹170, far above the low of ₹94.60; Mr Market is optimistic. But my rule is to buy with a margin of safety. At this price, with falling sales and unremarkable returns, I see no margin of safety. If I owned it, I would watch the next few quarters closely; if the sales decline reverses and margins hold, then a deeper review may be warranted. Today, however, this is a cyclical small-cap with cyclical risk, not a durable compounder.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer